News & Views
Scientists identify the best post-transplant drug combination
Jul 29 2011
Researchers from the University of Miami, in collaboration with the American Society of Nephrology, found that, following a multi-year study, the combination of two immunosuppressive drugs led to fewer instances of organ rejection and better health after transplant.
Medication following a transplant is a delicate balancing act as immunosuppressant drugs are essential for the acceptance of the new organ but can result in a weaker immune system, leaving the patient open to greater risk of infection, cancer and other risks.
In a study of 150 kidney transplant patients, the scientists found that using tacrolimus and mycophenolate mofetil (MMF) in combination provided the best long-term benefits and fewest side effects.
"We have been able to prove that the use of low-dose tacrolimus and MMF is safe and provides excellent outcomes over time to renal transplant patients," said Dr Giselle Guerra, lead author of the study.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia